All Articles
Contribution of front-line, standard-of-care drugs to bactericidal responses, resistance emergence, and cure in murine models of easy- or hard-to-treat tuberculosis disease
Abstract
By assessing the standard-of-care regimen for tuberculosis (TB) in BALB/c and C3HeB/FeJ mice, we demonstrate that rifampin, with or without pyrazinamide, is essential for an effective bactericidal response and suppression of resistance. Potency measurements in an in vitro lipid-rich model and a rabbit caseum assay recapitulate the significance of rifampin as a sterilizing agent. These outcomes align with clinical performance, thus emphasizing the value of in vitro predictive tools and murine TB models with human-like pathology.
Keywords: C3HeB/FeJ; caseum; relapse; rifafour; tuberculosis.
Affiliations
View full article
Related Publications
.png)
Strain diversity drives heterogeneous responses to tuberculosis combination therapy
Michelle H. Yoon
,
Peter H. Culviner
,
Mariana Pereira Moraes
,
Hidetomi Nitta
,
Nguyen Thuy Thuong Thuong
,

Revolutionizing tuberculosis regimen development
Kelly E Dooley
,
Rada Savic
,

Emergence of antibiotic-specific Mycobacterium tuberculosis phenotypes during prolonged treatment of mice
Elizabeth A Wynn
,
Christian Dide-Agossou
,
Reem Al Mubarak
,
Karen Rossmassler
,
Victoria Ektnitphong
,